NCT04245527撤回不适用
Joovvin' for Hormonal Health
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- ProofPilot
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Testosterone Change
研究概览
简要总结
8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •United States resident
排除标准
- •current Joovv or other photomodulation therapy user
- •under medical supervision for medically treatable illness
- •significant travel during study period
- •use of birth control
研究组 & 干预措施
Study Arm
Experimental
20 minutes Joovv Solo every day for 8 weeks.
干预措施: Joovv Infrared Light Device (Device)
结局指标
主要结局
Testosterone Change
时间窗: baseline to week 8
in males, change from baseline to week 8
change of thyroid-stimulating hormone (TSH)
时间窗: baseline to week 8
in females change in estrogen and progesterone from baseline to week 8
Self report general wellness
时间窗: baseline to week 8
series of questions at baseline and week 8 on general wellness (modified Short Form-36)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (Probe Substrate for Cytochrome P450 3A4)HealthyNCT03111511Janssen Sciences Ireland UC18
已完成
1 期
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and NorethindroneHealthyNCT02652650Janssen Research & Development, LLC18
撤回
1 期
Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440HealthyNCT03890341Janssen Research & Development, LLC
终止
1 期
A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy FemalesHealthyNCT03126097Janssen Research & Development, LLC18
已完成
2 期
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) LevelsDyslipidemiaNCT00688558Akros Pharma Inc.92